Literature DB >> 11237773

Pregnancy and radiation.

E Fenig1, M Mishaeli, Y Kalish, M Lishner.   

Abstract

The risk of foetal irradiation during pregnancy is discussed. It seems that, due to the low level of X-ray exposure to the foetus, neither diagnostic radiography nor nuclear diagnostic examination justifies termination of pregnancy. Radiotherapy for breast cancer, Hodgkin's disease and cervical cancer in pregnant women is reviewed. Radiation therapy for breast cancer is not an absolute contraindication for pregnancy and the risk-benefit assessment should be discussed with the mother. The risk to the foetus during radiotherapy for supradiaphragmatic Hodgkin's disease appears to be minimal, provided special attention is paid to the treatment techniques and the foetus is adequately shielded. Radiotherapy for the treatment of cervical cancer may be necessary during pregnancy, but the timing should be adjusted taking into consideration gestational age. Offspring of cancer patients who were treated by radiotherapy appear to be at little risk of childhood cancer or birth defects. Cancer patients should not be discouraged from having children and can expect a good outcome of pregnancy. However, in the non-pregnant woman, to further reduce any risk it is advisable to delay pregnancy for 12 months following completion of radiation therapy. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11237773     DOI: 10.1053/ctrv.2000.0193

Source DB:  PubMed          Journal:  Cancer Treat Rev        ISSN: 0305-7372            Impact factor:   12.111


  15 in total

Review 1.  Maintaining fertility in young women with breast cancer.

Authors:  Melissa C Hulvat; Jacqueline S Jeruss
Journal:  Curr Treat Options Oncol       Date:  2009-12

2.  Chromosome aberration and environmental physical activity: Down syndrome and solar and cosmic ray activity, Israel, 1990-2000.

Authors:  Eliahu G Stoupel; Helena Frimer; Zvi Appelman; Ziva Ben-Neriah; Hanna Dar; Moshe D Fejgin; Ruth Gershoni-Baruch; Esther Manor; Gad Barkai; Stavit Shalev; Zully Gelman-Kohan; Orit Reish; Dorit Lev; Bella Davidov; Boleslaw Goldman; Mordechai Shohat
Journal:  Int J Biometeorol       Date:  2005-06-30       Impact factor: 3.787

Review 3.  Management of Hematologic Malignancies: Special Considerations in Pregnant Women.

Authors:  Odelia Amit; Merav Barzilai; Irit Avivi
Journal:  Drugs       Date:  2015-10       Impact factor: 9.546

4.  Reduced Midbrain Dopamine Neuron Number in the Adult Non-human Primate Brain after Fetal Radiation Exposure.

Authors:  Lynn D Selemon; Anita Begovic
Journal:  Neuroscience       Date:  2020-07-11       Impact factor: 3.590

Review 5.  Management of breast cancer diagnosed during pregnancy.

Authors:  Hope S Rugo
Journal:  Curr Treat Options Oncol       Date:  2003-04

6.  Cancer, fertility preservation, and future pregnancy: a comprehensive review.

Authors:  Michelle L Matthews; Bradley S Hurst; Paul B Marshburn; Rebecca S Usadi; Margaret A Papadakis; Terry Sarantou
Journal:  Obstet Gynecol Int       Date:  2012-03-18

Review 7.  Fertility preservation in gynecological cancers.

Authors:  Shakuntala Chhabra; Imran Kutchi
Journal:  Clin Med Insights Reprod Health       Date:  2013-03-21

Review 8.  Fertility preservation in female cancer patients: An overview.

Authors:  Nalini Mahajan
Journal:  J Hum Reprod Sci       Date:  2015 Jan-Mar

Review 9.  Gynecologic malignancy in pregnancy.

Authors:  Yong Il Ji; Ki Tae Kim
Journal:  Obstet Gynecol Sci       Date:  2013-09-14

Review 10.  The treatment of hematologic malignancies in pregnancy.

Authors:  C Vandenbriele; D Dierickx; F Amant; M Delforge
Journal:  Facts Views Vis Obgyn       Date:  2010
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.